Novartis India Buys Minipress Brand For ₹1,250 Crore, Pfizer To Stop Selling Hypertension Drug[1]
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore[2]
What remains disputed or unverified
No disputed central claims are recorded for this story.
What is confirmed
Novartis India Buys Minipress Brand For ₹1,250 Crore, Pfizer To Stop Selling Hypertension Drug[1]
Novartis India to acquire Pfizer's ‘Minipress’ trademark for ₹1,250 crore[2]
Sources and ownership
This brief cites 2 reports from 2 sources (Free Press Journal, Business Line - Home) under 2 separate ownership groups. Sources under separate ownership are less likely to repeat the same reporting error. Cited Current publishes a template brief only when an event is corroborated by at least 2 independently owned sources or by an official or wire report.[1][2]
First detected September 7, 2026 at 07:21 UTC; the earliest cited report was published September 7, 2026 at 07:04 UTC. All times are UTC.[1][2]
No published comments yet. Be the first to add useful context.